4//SEC Filing
Versant Vantage I GP-GP, LLC 4
Accession 0000899243-20-034365
CIK 0001808158other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 9:05 PM ET
Size
20.4 KB
Accession
0000899243-20-034365
Insider Transaction Report
Form 4
Versant Vantage I GP, L.P.
10% Owner
Transactions
- Other
Common Shares
2020-12-15−8,579→ 76,158 total(indirect: See Footnote) - Other
Common Shares
2020-12-15−285,217→ 2,531,804 total(indirect: See Footnote) - Other
Common Shares
2020-12-15−21,707→ 192,683 total(indirect: See Footnote) - Other
Common Shares
2020-12-15−9,497→ 84,301 total(indirect: See Footnote)
Holdings
- 3,419,451(indirect: See Footnote)
Common Shares
- 608,282
Common Shares
Versant Vantage I GP-GP, LLC
10% Owner
Transactions
- Other
Common Shares
2020-12-15−285,217→ 2,531,804 total(indirect: See Footnote) - Other
Common Shares
2020-12-15−8,579→ 76,158 total(indirect: See Footnote) - Other
Common Shares
2020-12-15−9,497→ 84,301 total(indirect: See Footnote) - Other
Common Shares
2020-12-15−21,707→ 192,683 total(indirect: See Footnote)
Holdings
- 3,419,451(indirect: See Footnote)
Common Shares
- 608,282
Common Shares
Versant Vantage I, L.P.
10% Owner
Transactions
- Other
Common Shares
2020-12-15−285,217→ 2,531,804 total(indirect: See Footnote) - Other
Common Shares
2020-12-15−8,579→ 76,158 total(indirect: See Footnote) - Other
Common Shares
2020-12-15−9,497→ 84,301 total(indirect: See Footnote) - Other
Common Shares
2020-12-15−21,707→ 192,683 total(indirect: See Footnote)
Holdings
- 608,282
Common Shares
- 3,419,451(indirect: See Footnote)
Common Shares
Footnotes (10)
- [F1]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital V, L.P. ("VVC V"), to its partners, pursuant to a Rule 10b5-1 trading plan.
- [F10]Shares held by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("VV I GP") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F2]Shares held by VVC V. Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F3]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Affiliates Fund V, L.P. ("VAF V"), to its partners, pursuant to a Rule 10b5-1 trading plan.
- [F4]Shares held by VAF V. VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F5]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ophthalmic Affiliates, L.P. ("VOAF I"), to its partners, pursuant to a Rule 10b5-1 trading plan.
- [F6]Shares held by VOAF I. VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F7]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital V (Canada) LP ("VVC V (Canada)"), to its partners, pursuant to a Rule 10b5-1 trading plan.
- [F8]Shares held by VVC V (Canada). Versant Ventures V (Canada) GP-GP, Inc. ("VV V (Canada) GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V (Canada)") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
- [F9]Shares held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001777653
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 9:05 PM ET
- Size
- 20.4 KB